Lunit, a leader in AI-powered solutions for cancer diagnostics and therapeutics, has completed its acquisition of Volpara Health Technologies, a global frontrunner in medical software for breast cancer screening. This strategic acquisition, finalized within an impressive eight-month timeline, significantly enhances Lunit’s capabilities in AI-driven cancer diagnostics by integrating Volpara’s advanced breast health platform. Expanding Capabilities […]
Lunit (KRX:328130.KQ), a frontrunner in AI-powered solutions for cancer diagnostics and therapeutics, is marking a significant milestone in its expansion across Europe through two pivotal commercial agreements. The company has secured supply contracts with TeleDiag, the leading teleradiology group in France, and the central region branch of the Portuguese League Against Cancer (LPCC), signifying a […]
